Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1974 Jun 1;139(6):1382–1394. doi: 10.1084/jem.139.6.1382

INDUCTION OF PARTIAL IMMUNOLOGIC TOLERANCE IN RATS AND PROGRESSIVE LOSS OF CELLULAR ANTIGENICITY IN GROSS VIRUS LYMPHOMA

Harry L Ioachim 1, Steven E Keller 1, Brent H Dorsett 1, Antonia Pearse 1
PMCID: PMC2139688  PMID: 4208416

Abstract

Gross virus-induced lymphoma cells express strong virus-associated (Gross murine leukemia virus [G-MuLV]) antigens and are consistently rejected when grafted in normal adult syngeneic rats. By contrast, similar grafts are tolerated and allowed to grow progressively by rats that have been injected at birth with deaggregated G-MuLV antigens. However, the tolerance induced by this procedure is only partial as the grafted lymphoma cells lose their G-MuLV membrane antigens. These cells showing an antigenic disjunction, with negative membrane and positive cytoplasmic G-MuLV antigenic expression, become transplantable in normal-nonconditioned adult recipients. By further grafting, the expression of cytoplasmic G-MuLV antigens is similarly lost while the lymphoma cells substantially increase their transplantability, rate of growth, and capacity for metastasis.

Full Text

The Full Text of this article is available as a PDF (841.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin R. W., Price M. R., Robins R. A. Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes. Nat New Biol. 1972 Aug 9;238(84):185–186. doi: 10.1038/newbio238185a0. [DOI] [PubMed] [Google Scholar]
  2. Boyse E. A., Stockert E., Old L. J. Modification of the antigenic structure of the cell membrane by thymus-leukemia (TL) antibody. Proc Natl Acad Sci U S A. 1967 Sep;58(3):954–957. doi: 10.1073/pnas.58.3.954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DRESSER D. W. Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen. Immunology. 1962 May;5:378–388. [PMC free article] [PubMed] [Google Scholar]
  4. Feldman J. D. Immunological enhancement: a study of blocking antibodies. Adv Immunol. 1972;15:167–214. doi: 10.1016/s0065-2776(08)60685-9. [DOI] [PubMed] [Google Scholar]
  5. Fenyö E. M., Biberfeld P., Klein E. Studies on the relations between virus release and cellular immunosensitivity in Moloney lymphomas. J Natl Cancer Inst. 1969 May;42(5):837–855. [PubMed] [Google Scholar]
  6. Geering G., Old L. J., Boyse E. A. Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses. J Exp Med. 1966 Oct 1;124(4):753–772. doi: 10.1084/jem.124.4.753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hartley J. W., Rowe W. P., Capps W. I., Huebner R. J. Complement fixation and tissue culture assays for mouse leukemia viruses. Proc Natl Acad Sci U S A. 1965 May;53(5):931–938. doi: 10.1073/pnas.53.5.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Herberman R. B., Oren M. E. Immune response to Gross virus-induced lymphoma. I. Kinetics of cytotoxic antibody response. J Natl Cancer Inst. 1971 Feb;46(2):391–396. [PubMed] [Google Scholar]
  9. Huebner R. J., Todaro G. J. Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci U S A. 1969 Nov;64(3):1087–1094. doi: 10.1073/pnas.64.3.1087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ioachim H. L., Berwick L. Continuous viral replication and cellular neoplastic transformation in cultures of normal rat thymus infected with gross leukemia virus. Int J Cancer. 1968 Jan 15;3(1):61–73. doi: 10.1002/ijc.2910030109. [DOI] [PubMed] [Google Scholar]
  11. Ioachim H. L., Dorsett B., Sabbath M., Keller S. Loss and recovery of phenotypic expression of Gross leukaemia virus. Nat New Biol. 1972 Jun 14;237(76):215–218. doi: 10.1038/newbio237215b0. [DOI] [PubMed] [Google Scholar]
  12. Ioachim H. L., Sabbath M., Andersson B., Keller S. Viral and chemical leukemia in the rat: comparative study. J Natl Cancer Inst. 1971 Jul;47(1):161–177. [PubMed] [Google Scholar]
  13. Irvin G. L., 3rd, Eustace J. C., Fahey J. L. Inhancement activity of mouse immunoglobulin classes. J Immunol. 1967 Dec;99(6):1085–1091. [PubMed] [Google Scholar]
  14. KALISS N. Immunological enhancement of tumor homografts in mice: a review. Cancer Res. 1958 Oct;18(9):992–1003. [PubMed] [Google Scholar]
  15. Kafuko G. W., Burkitt D. P. Burkitt's lymphoma and malaria. Int J Cancer. 1970 Jul 15;6(1):1–9. doi: 10.1002/ijc.2910060102. [DOI] [PubMed] [Google Scholar]
  16. Klein E. Tumour immunology; escape mechanisms. Ann Inst Pasteur (Paris) 1972 Apr;122(4):593–602. [PubMed] [Google Scholar]
  17. Kobayashi H., Kuzumaki N., Gotoda E., Takeichi N., Sendo F. Specific antigenicity of tumors and immunological tolerance in the rat induced by Friend, Gross, and Rauscher viruses. Cancer Res. 1973 Jul;33(7):1598–1603. [PubMed] [Google Scholar]
  18. MEDAWAR P. B. The use of antigenic tissue extracts to weaken the immunological reaction against skin homografts in mice. Transplantation. 1963 Jan;1:21–38. doi: 10.1097/00007890-196301010-00004. [DOI] [PubMed] [Google Scholar]
  19. MITCHISON N. A. INDUCTION OF IMMUNOLOGICAL PARALYSIS IN TWO ZONES OF DOSAGE. Proc R Soc Lond B Biol Sci. 1964 Dec 15;161:275–292. doi: 10.1098/rspb.1964.0093. [DOI] [PubMed] [Google Scholar]
  20. OUCHTERLONY O. Diffusion-in-gel methods for immunological analysis. Prog Allergy. 1958;5:1–78. [PubMed] [Google Scholar]
  21. Old L. J., Stockert E., Boyse E. A., Kim J. H. Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro. J Exp Med. 1968 Mar 1;127(3):523–539. doi: 10.1084/jem.127.3.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Oldstone M. B., Aoki T., Dixon F. J. The antibody response of mice to murine leukemia virus in spontaneous infection: absence of classical immunologic tolerance (AKR mice-complement-fixing antibodies-lymphocytic choriomeningitis virus-immunofluorescence-glomerular deposits of antigen-antibody complexes). Proc Natl Acad Sci U S A. 1972 Jan;69(1):134–138. doi: 10.1073/pnas.69.1.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Povlsen C. O., Fialkow P. J., Klein E., Klein G., Rygaard J., Wiener F. Growth and antigenic properties of a biopsy-derived Burkitt's lymphoma in thymus-less (nude) mice. Int J Cancer. 1973 Jan 15;11(1):30–39. doi: 10.1002/ijc.2910110105. [DOI] [PubMed] [Google Scholar]
  24. Rosenberg E. B., Hill J., Ferarri A., Herberman R. B., Ting C. C., Mann D. L., Fahey J. Prolonged survival of tumor allografts in mice pretreated with soluble transplantation antigens. J Natl Cancer Inst. 1973 Jun;50(6):1453–1458. doi: 10.1093/jnci/50.6.1453. [DOI] [PubMed] [Google Scholar]
  25. Snell G. D., Winn H. J., Stimpfling J. H., Parker S. J. DEPRESSION BY ANTIBODY OF THE IMMUNE RESPONSE TO HOMOGRAFTS AND ITS ROLE IN IMMUNOLOGICAL ENHANCEMENT. J Exp Med. 1960 Aug 1;112(2):293–314. doi: 10.1084/jem.112.2.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Weigle W. O. Recent observations and concepts in immunological unresponsiveness and autoimmunity. Clin Exp Immunol. 1971 Oct;9(4):437–447. [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES